Aehr Test Systems AEHR
104.39
6.97
7.15%
as of 25 Sep
- Market cap
- $3.3B
- P/E
- 0.0×
Follow AEHR
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
13.10 | 12.77 | 29.86 | 57.42 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(2,640.01) | (580.60) | (366.36) | 1,567.27 | |
P/B ratio |
6.08 | 5.20 | 9.74 | 13.08 | |
Price to Tangible BV |
7.35 | 6.19 | 11.43 | 14.41 | |
EV/Sales |
12.81 | 12.31 | 29.19 | 55.22 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(72.36) | (122.26) | (177.44) | (834.18) | |
EV/FCF |
(44.81) | (56.05) | (108.32) | (513.61) | |
Quick Ratio |
3.00 | 4.95 | 5.57 | 7.50 | |
Current Ratio |
7.06 | 10.62 | 10.97 | 10.33 | |
Net Debt/EBITDA |
7.22 | 8.16 | 10.96 | 353.67 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.39 | 0.37 | 0.30 | 0.25 | |
Operating CF/Net income |
0.14 | 0.36 | 1.15 | 1.32 | |
Capex/Depreciation |
(1.51) | (0.54) | (0.09) | (0.15) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
25.97% | 30.07% | 30.71% | 19.35% | |
Selling, General and Administrative Expense of Revenue |
43.00% | 44.86% | 42.96% | 29.63% | |
Intangible Assets out of Total Assets |
0.15 | 0.14 | 0.13 | 0.08 | |
Share Based Compensation of Revenue |
15.23% | 18.63% | 13.42% | 9.90% | |
Graham Net Nets |
0.08 | 0.10 | 0.06 | 0.05 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.88%) | (1.33%) | (0.86%) | (0.26%) | |
Free Cash Flow Yield |
(2.18%) | (1.72%) | (0.90%) | (0.19%) | |
Revenue per Share |
0.37 | 0.33 | 0.34 | 0.61 | |
Operating CF per Share |
(0.01) | (0.04) | (0.12) | 0.06 | |
Capex per Share |
(0.05) | (0.02) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.06) | (0.05) | (0.12) | 0.06 | |
Cash per Share |
0.76 | 1.02 | 1.20 | 3.79 | |
Shareholders Equity per Share |
4.09 | 4.33 | 4.52 | 7.16 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.09 | 4.33 | 4.52 | 7.16 | |
Free Cash Flow |
(1.67) | (1.64) | (3.76) | 1.70 | |
Working Capital |
72.14 | 79.88 | 87.16 | 166.59 | |
Capital Expenditures |
(1.39) | (0.47) | (0.07) | (0.13) | |
Net Current Asset Value |
62.35 | 70.23 | 77.65 | 157.27 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.13 | 0.05 | 0.01 | 0.01 | |
Net Profit Margin |
(19.00%) | (32.68%) | (31.06%) | 7.39% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
10.81 | 8.81 | 11.90 | 15.83 | |
Average Payables |
4.48 | 4.20 | 4.53 | 6.74 | |
Average Inventory |
42.41 | 43.25 | 41.75 | 41.68 | |
Average Assets |
144.98 | 145.51 | 151.33 | 197.60 | |
Average Common Equity |
122.44 | 126.98 | 131.50 | 171.19 |
Columns are period end dates